The Flexivue System, a breakthrough implantable micro-lens treatment for presbyopia from Presbia Coöperatief was unveiled at the show and it is keenly anticipated that it will be in clinical trials in several European countries by the end of the year.
Supervision: Myth and Reality
The news broke at today's show that Alcon is to gain access to proprietary antibody fragment technology particularly suited to treat eye diseases with its plan to acquire ESBATech AG, a Swiss biotechnology firm.
Rayner, the world's first IOL manufacturer, unveiled a dynamic new brand identity at ESCRS and held a seminar today to highlight the success doctors are having with its range of toric IOLs. Headlined A Roadmap to Success the seminar featured presentations from seven European doctors relating their experiences of using Rayner's toric IOLs.
Breaking news from Day 3 of ESCRS
Combind cataract and vitreoretinal surgery
A review of the role and efficacy of anti-VEGF therapy in macular disease
Cataract surgery in patients with pre-existing AMD: Risks and Benefits
Breaking news from Day 2 of ESCRS
New insights into ectopia lentis
Ocular Biometry and Straylight
New at congress, Zeiss Toric Solution is a combination of tools to allow physicians to implant and align toric lenses faster and easier.
Geuder has launched the Megatron S4 system, an upgrade on the company?s Megatron S3, which has sold 700 units worldwide since its launch in 2001. “The launch of the S4 marks the successful end of about three years work,”said Dirk Mittnacht, product manager systems for Geuder.
Anterior chamber lenses in the management of subluxated lenses
Corneal stromal effects and profiles with deep femtosecond laser ablations
Canon Europe, revealed its new CX-1, a world first in retinal imaging technology for the first time at this year's ESCRS Congress.
PRK and LASEK in children
IOLs anatomical prerequisites for accommodation?
Confocal microscopy as an evaluation tool of wound healing in corneal surgery
Anterior and posterior capsulorhexis in children
The LENSTAR LS900® was introduced at last year's ESCRS and provides the user with a complete biometrical assessment of the patient?s eye in a single measurement procedure, including lens thickness, anterior chamber depth (lens position) and retinal thickness.
Four new products launched at today's show to help facilitate surgeons? daily work included a new modular phaco machine for cataract surgery and solution for posterior vitrectomy, a new single-piece hydrophilic pre-loaded IOL, a new viscoelastic and a new lubricant and contact agent for the protection of the corneal surface during surgery. The quartet have all been launched by Croma.
Breaking news from Day 1 of ESCRS
Hoya Surgical Products now has, what it claims to be, the Sharpest Edge on the market. The yellow aspheric blue-light filter IOLS iSymm has undergone a unique manufacturing process which makes it the sharpest of all commercially available IOLs currently in the market.
Interim results from a Phase II study by Gene Signal suggest that antisense oligonucleotide GS-101 is safe and effective at inhibiting abnormal corneal new blood vessel growth.
The first European Master's degree in Clinical and Surgical Ophthalmology, a prestigious international project of advanced studies for ophthalmological professionals, was presented in Lugano (Switzerland) by the European School for Advanced Studies in Ophthalmology.
$400 million in cash has secured the acquisition of Visiogen for Abbott and secured the latter a next-generation accommodating IOL technology to help presbyopia in cataract patients.
A new study conducted by researchers at the University of Aberdeen, Scotland, has found that the brain predicts the consequences of eye movement even before the eyes take in a new scene.
The pathology of glaucoma is likely to be related to the presence and levels of selenium, according to the results of a study published in the August issue of the British Journal of Ophthalmology.
High levels of the enzyme arginase contributes to vascular eye damage, and therapies to lower its levels could halt progression of diabetic retinopathy (DR), according to researchers at the Medical College of Georgia (MCG) School of Medicine, USA.
